"CD28, TNF Receptor, and IL-12 Are Critical for CD4-Independent Cross-Priming of Therapeutic Antitumor CD8+ T Cells" by Hong-Ming Hu

Selected Works of Walter J. Urba, MD, PhD

Follow Contact

Article

CD28, TNF Receptor, and IL-12 Are Critical for CD4-Independent Cross-Priming of Therapeutic Antitumor CD8+ T Cells

Journal of Immunology (2002)

Hong-Ming Hu, Providence Portland Medical Center
Hauke Winter, Providence Portland Medical Center
Jun Ma, Providence Portland Medical Center
Michael Croft, La Jolla Institute for Allergy and Immunology
Walter J. Urba, Providence Portland Medical Center
Bernard A. Fox, Providence Portland Medical Center

Link

Disciplines

Biology,
Molecular Biology and
Immunology and Infectious Disease

Publication Date

November 1, 2002

DOI

10.4049/jimmunol.169.9.4897

Citation Information

Hong-Ming Hu, Hauke Winter, Jun Ma, Michael Croft, et al.. "CD28, TNF Receptor, and IL-12 Are Critical for CD4-Independent Cross-Priming of Therapeutic Antitumor CD8+ T Cells" Journal of Immunology Vol. 169 Iss. 9 (2002) p. 4897 - 4904
Available at: http://works.bepress.com/walter-urba/227/